Avidity Biosciences

top of page

Aug 13

Avidity Biosciences' CEO Sarah Boyce discusses the company's Exon 44 skipping data in DMD that showed a 25% increase in dystrophin production

She describes how this PMO based antibody oligonucleotide conjugate works and why she believes the result validates her belief that...

Antibody oligonucleotide conjugates as an RNA strategy with the CEO of Avidity Biosciences

Nov 1, 2023

Bright Minds

Antibody oligonucleotide conjugates as an RNA strategy with the CEO of Avidity Biosciences

Sarah Boyce explains the rationale for using AOCs against muscle disorders like Myotonic dystrophy type 1 and DMD.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh